Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients
1 other identifier
interventional
800
1 country
1
Brief Summary
In the 5G era with the revolutionary improvement of network speed, digital medical care has brought great convenience to health services. There is a lack of mobile medical data on cancer care worldwide. We designed an applet based on mobile intelligent electronic devices with a doctor-patient dual interface for the perioperative management of cancer patients and verified its applicability in the general population. This study aims to specifically improve the applet according to the characteristics of cancer patients, use it to accurately manage and intervene cancer patients, and establish a rapid doctor-patient communication platform, hoping to improve prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Jul 2023
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2022
CompletedFirst Posted
Study publicly available on registry
August 16, 2022
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 21, 2023
December 1, 2023
1.5 years
August 10, 2022
December 20, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Acceptability of the applet by cancer patients as assessed by questionnaire
Investigated by a questionnaire with 33 questions, and compared with other mobile medical methods to explore the accessibility
3 months
Acceptability of the applet by medical oncology staff as assessed by questionnaire
The questionnaire includes 22 questions, collecting information on attitude feedback, time input, and training cost of medical staff using the mobile medical applet
3 months
Secondary Outcomes (3)
Self-reported quality of life as assessed by ED-5Q-5L scale
3 months
Psychological status as assessed by the HADS scale
3 months
Symptom distress as assessed by the MD Anderson symptom scale
3 months
Study Arms (1)
Health intervention based on intelligent applet
EXPERIMENTALHealth interventions using electronic applet, including nutrition, psychology, and patient self-management components.
Interventions
Patients are jointly managed by a MDT team based on the applet. The supportive intervention based on the applet mainly includes three parts: Nutrition, psychology, and patient management which includes four main parts: Cancer patient education, self-management, patient community, and real-time communication.
Eligibility Criteria
You may qualify if:
- Sign and date informed consent;
- Commit to abide by the research procedures and cooperate with the implementation of the whole research process ;
- Can adhere to and cooperate with research intervention;
- Tumor patients;
- Patients/family members can use smart phones to access the Internet;
- Patients/family members have sufficient cognitive and reading ability;
- No mental illness;
- No serious visual impairment
You may not qualify if:
- Equipped with specific devices (such as cardiac pacemaker);
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
Shanghai, 200025, China
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Lei Huang, PhD, MD
Ruijin Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Fellow; PI
Study Record Dates
First Submitted
August 10, 2022
First Posted
August 16, 2022
Study Start
July 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
December 21, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share